Table 3.
Detection methods for SARS-CoV-2.
Type | RT-PCR | RT-LAMP | CRISPR-Cas12 | Enzyme linked immuno- assay | Rapid diagnostic test |
---|---|---|---|---|---|
Detection | N gene, E gene, RdRp | N gene, S gene, ORF1ab, | N gene, E gene | IgM/IgG antibodies | IgM/IgG antibodies |
Sample type | Nasopharyngeal swab, Oropharyngeal swab | Nasopharyngeal swab, Oropharyngeal swab | Nasopharyngeal swab, Oropharyngeal swab | Plasma or Serum | Plasma or Serum |
Time point | Symptom onset | Symptom onset | Symptom onset | Days/weeks after symptom onset | Days/weeks after symptom onset |
Advantages | High accuracy, High reliability, Direct detection | High accuracy, High reliability, Rapid detection, Color visualized by the naked eye | High accuracy High reliability | High specificity | Low cost, Ease of use, High specificity |
Disadvantages | Labor intensive, Errors with sample collection | Carry-over contamination | High limit of detection | Lower sensitivity | Lower sensitivity |
References | (74, 78) | (87, 88) | (89) | (78–80) | (78, 80, 90) |
RT-PCR testing is highly sensitive and widely applied. Limitations are false positive results and prolonged test positivity after recovery from active COVID-19. The characteristics of serology tests for antibodies and innovative CRISPR-Cas methods are shown.
RdRp: RNA dependent RNA polymerase.